cholesterol emboli syndrome
Last reviewed 01/2018
The cholesterol emboli syndrome is a multi-system disease which may complicate:
- arteriography
- thrombolysis
- anticoagulation
- vascular surgery
The characteristic clinical triad is:
- livedo reticularis
- renal failure
- eosinophilia
Multiple treatment regimens have been generally unsuccessful in altering the course of the disease process. The most significant impact on the disease can be made by its prevention
- thrombolytic and anticoagulant treatments are not indicated and only supportive care for such symptoms as hypertension, ulceration, and gangrene is advocated
- prognosis depends on the extent of the systemic disease and a high rate of mortality (75–80%) is recorded due to multifactorial, cardiac, and renal aetiologies
-
prognosis is poor with high mortality and the treatment is only supportive
Reference: